Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal muscular atrophy.

K Talbot1

  • 1Department of Neurology, Radcliffe Infirmary, Oxford, UK.

Journal of Inherited Metabolic Disease
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Spinal muscular atrophy (SMA) is a childhood neuromuscular disease linked to the SMN gene. Reduced full-length SMN protein levels correlate with disease severity, impacting motor neurons.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.

Molecular psychiatry·2025
Same author

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Same author

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.

Journal of the neurological sciences·2021
Same author

The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review.

British journal of anaesthesia·2019
Same author

Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.

Acta neurologica Scandinavica·2018
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Spinal muscular atrophy (SMA) is a leading cause of childhood disability, characterized by progressive muscle weakness and often fatal outcomes.
  • SMA is caused by mutations in the Survival Motor Neuron (SMN) gene, located in a complex duplicated region on chromosome 5.
  • The severity of SMA directly correlates with the amount of functional, full-length SMN protein produced by the individual.

Purpose of the Study:

  • To investigate the genetic basis of Spinal Muscular Atrophy (SMA).
  • To understand the relationship between SMN gene mutations, SMN protein levels, and disease severity.
  • To explore the functional role of the SMN protein and its implications for motor neuron health.

Main Methods:

  • Molecular genetic studies analyzing SMN gene deletions and conversions.
  • Correlation analysis between SMN protein levels and clinical measures of muscle weakness.
  • Review of theoretical frameworks for motor neuron vulnerability in mRNA processing disorders.

Main Results:

  • Patients with SMA are often compound heterozygotes for deleted and converted SMN alleles.
  • A model is supported where decreasing SMN protein levels predict increasing muscle weakness.
  • The SMN protein is implicated in ribonucleoprotein biogenesis and mRNA post-transcriptional processing.

Conclusions:

  • The amount of full-length SMN protein is a critical determinant of SMA severity.
  • Disturbances in mRNA processing and transport due to SMN deficiency may underlie motor neuron vulnerability in SMA.
  • Further understanding of SMN function is crucial for developing effective SMA therapies.